Optical coherence tomography as a potential readout in clinical trials

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 3, 2010, Pages 153-160

  Greenberg, Benjamin M ^a   Frohman, Elliot ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

macula; multiple sclerosis; neurodegeneration; optical coherence tomography; retinal nerve fiber layer

Indexed keywords

ALZHEIMER DISEASE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE MARKER; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; EYE FUNDUS PHOTOGRAPHY; EYE PHOTOGRAPHY; GLAUCOMA; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROPROTECTION; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; RETINA MACULA DEGENERATION; RETINA NERVE CELL; REVIEW; SENSITIVITY AND SPECIFICITY; SYNAPTIC TRANSMISSION;

EID: 77953385483     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285610368890     Document Type: Review

References (35)

1. Ahlers, C. and Schmidt-Erfurth, U. (2009) Three-dimensional high resolution OCT imaging of macular pathology. Opt Express 17: 4037-4045.
2. Altintas, O., Iseri, P., Ozkan, B. and Caglar, Y. ( 2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 116: 137-146.
3. Berisha, F., Feke, G.T., Trempe, C.L., McMeel, J.W. and Schepens, C.L. ( 2007) Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 48: 2285-2289.
4. Blanks, J.C., Hinton, D.R., Sadun, A.A. and Miller, C.A. ( 1989) Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 501: 364-372.
5. Chang, R. and Budenz, D.L. ( 2008) New developments in optical coherence tomography for glaucoma. Curr Opin Ophthalmol 19: 127-135.
6. Chen, J. and Lee, L. ( 2007) Clinical applications and new developments of optical coherence tomography: an evidence-based review. Clin Exp Optom 90: 317-335.
7. Costello, F., Hodge, W., Pan, Y.I., Eggenberger, E., Coupland, S. and Kardon, R.H. ( 2008) Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 14: 893-905.
8. Daumer, M., Neuhaus, A., Morrissey, S., Hintzen, R. and Ebers, G.C. (2009) MRI as an outcome in multiple sclerosis clinical trials. Neurology 72: 705-711.
9. de Seze, J., Blanc, F., Jeanjean, L., Zephir, H., Labauge, P., Bouyon, M. et al. (2008) Optical coherence tomography in neuromyelitis optica. Arch Neurol 65: 920-923.
10. Djamgoz, M.B., Hankins, M.W., Hirano, J. and Archer, S.N. ( 1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37: 3509-3529.
11. Gambichler, T., Moussa, G., Sand, M., Sand, D., Altmeyer, P. and Hoffmann, K. ( 2005) Applications of optical coherence tomography in dermatology. J Dermatol Sci 40: 85-94.
12. Gimbel, C. ( 2008) Optical coherence tomography diagnostic imaging. Gen Dent 56: 750-757; quiz 758-759, 768.
13. Goh, A.C., Tresser, N.J., Shen, S.S. and Lerner, S.P. ( 2008) Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 72: 133-137.
14. Gordon-Lipkin, E., Chodkowski, B., Reich, D.S., Smith, S.A., Pulicken, M., Balcer, L.J. et al. (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69: 1603-1609.
15. Guagliumi, G. and Sirbu, V. ( 2008) Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 72: 237-247.
16. Hinton, D.R., Sadun, A.A., Blanks, J.C. and Miller, C.A. ( 1986) Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315: 485-487.
17. Hsiung, P.L., Phatak, D.R., Chen, Y., Aguirre, A.D., Fujimoto, J.G. and Connolly, J.L. ( 2007) Benign and malignant lesions in the human breast depicted with ultrahigh resolution and three-dimensional optical coherence tomography. Radiology 244: 865-874.
18. Huang, D., Swanson, E.A., Lin, C.P., Schuman, J.S., Stinson, W.G., Chang, W. et al. (1991) Optical coherence tomography. Science 254: 1178-1181.
19. Inzelberg, R., Ramirez, J.A., Nisipeanu, P. and Ophir, A. ( 2004) Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44: 2793-2797.
20. Jafri, M.S., Farhang, S., Tang, R.S., Desai, N., Fishman, P.S., Rohwer, R.G. et al. (2005) Optical coherence tomography in the diagnosis and treatment of neurological disorders. J Biomed Opt 10: 051603.
21. Leung, C.K., Mohamed, S., Leung, K.S., Cheung, C.Y., Chan, S.L., Cheng, D.K. et al. (2006) Retinal nerve fiber layer measurements in myopia: An optical coherence tomography study. Invest Ophthalmol Vis Sci 47: 5171-5176.
22. Naismith, R.T., Xu, J., Tutlam, N.T., Snyder, A., Benzinger, T., Shimony, J. et al. (2009) Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 72: 589-594.
23. Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R. and Hugon, J. ( 2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420: 97-99.
24. Parisi, V., Manni, G., Spadaro, M., Colacino, G., Restuccia, R., Marchi, S. et al. (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40: 2520-2527.
25. Parisi, V., Restuccia, R., Fattapposta, F., Mina, C., Bucci, M.G. and Pierelli, F. ( 2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112: 1860-1867.
26. Pierre-Kahn, V., Tadayoni, R., Haouchine, B., Massin, P. and Gaudric, A. ( 2005) Comparison of optical coherence tomography models OCT 1 and Stratus OCT for macular retinal thickness measurement. Br J Ophthalmol 89: 1581-1585.
27. Pulicken, M., Gordon-Lipkin, E., Balcer, L.J., Frohman, E., Cutter, G. and Calabresi, P.A. ( 2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69: 2085-2092.
28. Sadun, A.A. and Bassi, C.J. ( 1990) Optic nerve damage in Alzheimer's disease. Ophthalmology 97: 9-17.
29. Schuman, J.S., Pedut-Kloizman, T., Hertzmark, E., Hee, M.R., Wilkins, J.R., Coker, J.G. et al. (1996) Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology 103: 1889-1898.
30. Sergott, R.C., Frohman, E., Glanzman, R. and Al-Sabbagh, A. ( 2007) The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 263: 3-14.
31. Tearney, G.J., Jang, I.K. and Bouma, B.E. ( 2006) Optical coherence tomography for imaging the vulnerable plaque. J Biomed Opt 11: 021002.
32. Trick, G.L., Trick, L.R., Morris, P. and Wolf, M. ( 1995) Visual field loss in senile dementia of the Alzheimer's type. Neurology 45: 68-74.
33. Trip, S.A., Schlottmann, P.G., Jones, S.J., Li, W.Y., Garway-Heath, D.F., Thompson, A.J. et al. (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31: 286-293.
34. Zangwill, L.M., Williams, J., Berry, C.C., Knauer, S. and Weinreb, R.N. ( 2000) A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma. Ophthalmology 107: 1309-1315.
35. Zhang, N., Hoffmeyer, G.C., Young, E.S., Burns, R.E., Winter, K.P., Stinnett, S.S. et al. (2007) Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol 144: 37-44.